GO Term	Description	P-value	FDR q-value	Enrichment	N	B	n	b	Genes
GO:0016477	cell migration	7.66E-7	5.06E-3	2.20	714	55	177	30	[SLC7A7  -  solute carrier family 7 (amino acid transporter light chain, y+l system), member 7, DOCK4  -  dedicator of cytokinesis 4, GPC6  -  glypican 6, GPX1  -  glutathione peroxidase 1, PLXNB1  -  plexin b1, DPP4  -  dipeptidyl-peptidase 4, KANK1  -  kn motif and ankyrin repeat domains 1, SEMA5A  -  sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (tm) and short cytoplasmic domain, (semaphorin) 5a, NRP2  -  neuropilin 2, NR4A2  -  nuclear receptor subfamily 4, group a, member 2, MEF2C  -  myocyte enhancer factor 2c, GPC4  -  glypican 4, ITGB3  -  integrin, beta 3 (platelet glycoprotein iiia, antigen cd61), PTK7  -  protein tyrosine kinase 7, PREX1  -  phosphatidylinositol-3,4,5-trisphosphate-dependent rac exchange factor 1, DIXDC1  -  dix domain containing 1, SATB2  -  satb homeobox 2, MET  -  met proto-oncogene, DNER  -  delta/notch-like egf repeat containing, EXT1  -  exostosin glycosyltransferase 1, SLC7A5  -  solute carrier family 7 (amino acid transporter light chain, l system), member 5, SDC2  -  syndecan 2, AUTS2  -  autism susceptibility candidate 2, THBS1  -  thrombospondin 1, CX3CR1  -  chemokine (c-x3-c motif) receptor 1, ANXA1  -  annexin a1, DISC1  -  disrupted in schizophrenia 1, FAT1  -  fat atypical cadherin 1, NRCAM  -  neuronal cell adhesion molecule, LAMB1  -  laminin, beta 1]
GO:0048870	cell motility	1.64E-6	5.43E-3	2.08	714	62	177	32	[DST  -  dystonin, SLC7A7  -  solute carrier family 7 (amino acid transporter light chain, y+l system), member 7, DOCK4  -  dedicator of cytokinesis 4, GPC6  -  glypican 6, GPX1  -  glutathione peroxidase 1, DPP4  -  dipeptidyl-peptidase 4, PLXNB1  -  plexin b1, KANK1  -  kn motif and ankyrin repeat domains 1, SEMA5A  -  sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (tm) and short cytoplasmic domain, (semaphorin) 5a, NRP2  -  neuropilin 2, NR4A2  -  nuclear receptor subfamily 4, group a, member 2, MEF2C  -  myocyte enhancer factor 2c, GPC4  -  glypican 4, ITGB3  -  integrin, beta 3 (platelet glycoprotein iiia, antigen cd61), ADCY3  -  adenylate cyclase 3, PTK7  -  protein tyrosine kinase 7, PREX1  -  phosphatidylinositol-3,4,5-trisphosphate-dependent rac exchange factor 1, DIXDC1  -  dix domain containing 1, SATB2  -  satb homeobox 2, MET  -  met proto-oncogene, DNER  -  delta/notch-like egf repeat containing, EXT1  -  exostosin glycosyltransferase 1, SLC7A5  -  solute carrier family 7 (amino acid transporter light chain, l system), member 5, SDC2  -  syndecan 2, AUTS2  -  autism susceptibility candidate 2, THBS1  -  thrombospondin 1, CX3CR1  -  chemokine (c-x3-c motif) receptor 1, ANXA1  -  annexin a1, DISC1  -  disrupted in schizophrenia 1, FAT1  -  fat atypical cadherin 1, LAMB1  -  laminin, beta 1, NRCAM  -  neuronal cell adhesion molecule]
GO:0006928	movement of cell or subcellular component	1.93E-6	4.25E-3	1.78	714	104	177	46	[SLC7A7  -  solute carrier family 7 (amino acid transporter light chain, y+l system), member 7, DST  -  dystonin, NEO1  -  neogenin 1, DOCK4  -  dedicator of cytokinesis 4, KIF5C  -  kinesin family member 5c, GPC6  -  glypican 6, MYH10  -  myosin, heavy chain 10, non-muscle, GPX1  -  glutathione peroxidase 1, NFIB  -  nuclear factor i/b, SEMA5A  -  sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (tm) and short cytoplasmic domain, (semaphorin) 5a, KANK1  -  kn motif and ankyrin repeat domains 1, DPP4  -  dipeptidyl-peptidase 4, PLXNB1  -  plexin b1, NRP2  -  neuropilin 2, SHANK3  -  sh3 and multiple ankyrin repeat domains 3, NR4A2  -  nuclear receptor subfamily 4, group a, member 2, MEF2C  -  myocyte enhancer factor 2c, GPC4  -  glypican 4, DPYSL2  -  dihydropyrimidinase-like 2, ITGB3  -  integrin, beta 3 (platelet glycoprotein iiia, antigen cd61), ADCY3  -  adenylate cyclase 3, CYFIP1  -  cytoplasmic fmr1 interacting protein 1, PTK7  -  protein tyrosine kinase 7, PREX1  -  phosphatidylinositol-3,4,5-trisphosphate-dependent rac exchange factor 1, DIXDC1  -  dix domain containing 1, SATB2  -  satb homeobox 2, TRIO  -  trio rho guanine nucleotide exchange factor, EPHB2  -  eph receptor b2, MET  -  met proto-oncogene, DNER  -  delta/notch-like egf repeat containing, EXT1  -  exostosin glycosyltransferase 1, KIF13B  -  kinesin family member 13b, SDC2  -  syndecan 2, SLC7A5  -  solute carrier family 7 (amino acid transporter light chain, l system), member 5, AUTS2  -  autism susceptibility candidate 2, THBS1  -  thrombospondin 1, CX3CR1  -  chemokine (c-x3-c motif) receptor 1, ANXA1  -  annexin a1, MYO5C  -  myosin vc, PRKCA  -  protein kinase c, alpha, DISC1  -  disrupted in schizophrenia 1, MYO5A  -  myosin va (heavy chain 12, myoxin), MYO1E  -  myosin ie, FAT1  -  fat atypical cadherin 1, NRCAM  -  neuronal cell adhesion molecule, LAMB1  -  laminin, beta 1]
GO:0022603	regulation of anatomical structure morphogenesis	2.25E-6	3.71E-3	1.88	714	86	177	40	[HLA-G  -  major histocompatibility complex, class i, g, GPC6  -  glypican 6, MYH10  -  myosin, heavy chain 10, non-muscle, SYT17  -  synaptotagmin xvii, NFIB  -  nuclear factor i/b, PLXNB1  -  plexin b1, SEMA5A  -  sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (tm) and short cytoplasmic domain, (semaphorin) 5a, KANK1  -  kn motif and ankyrin repeat domains 1, PRICKLE1  -  prickle homolog 1 (drosophila), SHANK3  -  sh3 and multiple ankyrin repeat domains 3, MEF2C  -  myocyte enhancer factor 2c, SASH1  -  sam and sh3 domain containing 1, ADA  -  adenosine deaminase, PTGS2  -  prostaglandin-endoperoxide synthase 2 (prostaglandin g/h synthase and cyclooxygenase), GPC4  -  glypican 4, BCL11A  -  b-cell cll/lymphoma 11a (zinc finger protein), NLGN1  -  neuroligin 1, TANC2  -  tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 2, DPYSL2  -  dihydropyrimidinase-like 2, PTK7  -  protein tyrosine kinase 7, CYFIP1  -  cytoplasmic fmr1 interacting protein 1, CTNNB1  -  catenin (cadherin-associated protein), beta 1, 88kda, PREX1  -  phosphatidylinositol-3,4,5-trisphosphate-dependent rac exchange factor 1, PRICKLE2  -  prickle homolog 2 (drosophila), AR  -  androgen receptor, EPHB2  -  eph receptor b2, CUX1  -  cut-like homeobox 1, DOCK1  -  dedicator of cytokinesis 1, KIF13B  -  kinesin family member 13b, SDC2  -  syndecan 2, THBS1  -  thrombospondin 1, PRKCB  -  protein kinase c, beta, CX3CR1  -  chemokine (c-x3-c motif) receptor 1, ANXA1  -  annexin a1, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, FOXP1  -  forkhead box p1, HECW2  -  hect, c2 and ww domain containing e3 ubiquitin protein ligase 2, PRKCA  -  protein kinase c, alpha, DISC1  -  disrupted in schizophrenia 1, NRCAM  -  neuronal cell adhesion molecule]
GO:0045595	regulation of cell differentiation	4.37E-6	5.77E-3	1.66	714	129	177	53	[LILRB2  -  leukocyte immunoglobulin-like receptor, subfamily b (with tm and itim domains), member 2, HLA-G  -  major histocompatibility complex, class i, g, CASZ1  -  castor zinc finger 1, SYT17  -  synaptotagmin xvii, HLA-DRB1  -  major histocompatibility complex, class ii, dr beta 1, PLXNB1  -  plexin b1, PBX1  -  pre-b-cell leukemia homeobox 1, SHANK3  -  sh3 and multiple ankyrin repeat domains 3, SHANK2  -  sh3 and multiple ankyrin repeat domains 2, PLCB1  -  phospholipase c, beta 1 (phosphoinositide-specific), BCL11A  -  b-cell cll/lymphoma 11a (zinc finger protein), NLGN1  -  neuroligin 1, DPYSL3  -  dihydropyrimidinase-like 3, TANC2  -  tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 2, DPYSL2  -  dihydropyrimidinase-like 2, CTNNB1  -  catenin (cadherin-associated protein), beta 1, 88kda, VDR  -  vitamin d (1,25- dihydroxyvitamin d3) receptor, PREX1  -  phosphatidylinositol-3,4,5-trisphosphate-dependent rac exchange factor 1, HLA-B  -  major histocompatibility complex, class i, b, DIXDC1  -  dix domain containing 1, AR  -  androgen receptor, CUX1  -  cut-like homeobox 1, KIF13B  -  kinesin family member 13b, MSR1  -  macrophage scavenger receptor 1, SDC2  -  syndecan 2, CX3CR1  -  chemokine (c-x3-c motif) receptor 1, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, DISC1  -  disrupted in schizophrenia 1, SEMA5A  -  sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (tm) and short cytoplasmic domain, (semaphorin) 5a, KANK1  -  kn motif and ankyrin repeat domains 1, SNAP25  -  synaptosomal-associated protein, 25kda, PRICKLE1  -  prickle homolog 1 (drosophila), MEF2C  -  myocyte enhancer factor 2c, NR2F1  -  nuclear receptor subfamily 2, group f, member 1, ADA  -  adenosine deaminase, PTGS2  -  prostaglandin-endoperoxide synthase 2 (prostaglandin g/h synthase and cyclooxygenase), ITGB3  -  integrin, beta 3 (platelet glycoprotein iiia, antigen cd61), PTK7  -  protein tyrosine kinase 7, CYFIP1  -  cytoplasmic fmr1 interacting protein 1, ST7  -  suppression of tumorigenicity 7, TRIO  -  trio rho guanine nucleotide exchange factor, EPHB2  -  eph receptor b2, DOCK1  -  dedicator of cytokinesis 1, THBS1  -  thrombospondin 1, PRKCB  -  protein kinase c, beta, ANXA1  -  annexin a1, TCF4  -  transcription factor 4, FOXP1  -  forkhead box p1, PRKCA  -  protein kinase c, alpha, NEGR1  -  neuronal growth regulator 1, HECW2  -  hect, c2 and ww domain containing e3 ubiquitin protein ligase 2, PTPRC  -  protein tyrosine phosphatase, receptor type, c, NRCAM  -  neuronal cell adhesion molecule]
GO:0010595	positive regulation of endothelial cell migration	6.22E-6	6.85E-3	3.67	714	11	177	10	[SEMA5A  -  sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (tm) and short cytoplasmic domain, (semaphorin) 5a, NRP2  -  neuropilin 2, THBS1  -  thrombospondin 1, SASH1  -  sam and sh3 domain containing 1, ANXA1  -  annexin a1, PRKCA  -  protein kinase c, alpha, PTGS2  -  prostaglandin-endoperoxide synthase 2 (prostaglandin g/h synthase and cyclooxygenase), MET  -  met proto-oncogene, FOXP1  -  forkhead box p1, ITGB3  -  integrin, beta 3 (platelet glycoprotein iiia, antigen cd61)]
GO:0040011	locomotion	1.5E-5	1.42E-2	1.90	714	70	177	33	[DST  -  dystonin, SLC7A7  -  solute carrier family 7 (amino acid transporter light chain, y+l system), member 7, DOCK4  -  dedicator of cytokinesis 4, GPC6  -  glypican 6, GPX1  -  glutathione peroxidase 1, DPP4  -  dipeptidyl-peptidase 4, PLXNB1  -  plexin b1, SEMA5A  -  sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (tm) and short cytoplasmic domain, (semaphorin) 5a, KANK1  -  kn motif and ankyrin repeat domains 1, NRP2  -  neuropilin 2, NR4A2  -  nuclear receptor subfamily 4, group a, member 2, MEF2C  -  myocyte enhancer factor 2c, GPC4  -  glypican 4, ITGB3  -  integrin, beta 3 (platelet glycoprotein iiia, antigen cd61), ADCY3  -  adenylate cyclase 3, PTK7  -  protein tyrosine kinase 7, PREX1  -  phosphatidylinositol-3,4,5-trisphosphate-dependent rac exchange factor 1, DIXDC1  -  dix domain containing 1, SATB2  -  satb homeobox 2, MET  -  met proto-oncogene, DNER  -  delta/notch-like egf repeat containing, EXT1  -  exostosin glycosyltransferase 1, SLC7A5  -  solute carrier family 7 (amino acid transporter light chain, l system), member 5, SDC2  -  syndecan 2, PLAUR  -  plasminogen activator, urokinase receptor, AUTS2  -  autism susceptibility candidate 2, THBS1  -  thrombospondin 1, CX3CR1  -  chemokine (c-x3-c motif) receptor 1, ANXA1  -  annexin a1, DISC1  -  disrupted in schizophrenia 1, FAT1  -  fat atypical cadherin 1, NRCAM  -  neuronal cell adhesion molecule, LAMB1  -  laminin, beta 1]
GO:1904018	positive regulation of vasculature development	2.38E-5	1.96E-2	3.63	714	10	177	9	[SEMA5A  -  sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (tm) and short cytoplasmic domain, (semaphorin) 5a, CX3CR1  -  chemokine (c-x3-c motif) receptor 1, PRKCB  -  protein kinase c, beta, THBS1  -  thrombospondin 1, SASH1  -  sam and sh3 domain containing 1, ANXA1  -  annexin a1, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, PRKCA  -  protein kinase c, alpha, PTGS2  -  prostaglandin-endoperoxide synthase 2 (prostaglandin g/h synthase and cyclooxygenase)]
GO:0045766	positive regulation of angiogenesis	2.38E-5	1.74E-2	3.63	714	10	177	9	[SEMA5A  -  sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (tm) and short cytoplasmic domain, (semaphorin) 5a, SASH1  -  sam and sh3 domain containing 1, THBS1  -  thrombospondin 1, PRKCB  -  protein kinase c, beta, CX3CR1  -  chemokine (c-x3-c motif) receptor 1, ANXA1  -  annexin a1, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, PTGS2  -  prostaglandin-endoperoxide synthase 2 (prostaglandin g/h synthase and cyclooxygenase), PRKCA  -  protein kinase c, alpha]
GO:2000145	regulation of cell motility	4.15E-5	2.74E-2	1.98	714	55	177	27	[DOCK4  -  dedicator of cytokinesis 4, EPPK1  -  epiplakin 1, KANK1  -  kn motif and ankyrin repeat domains 1, SEMA5A  -  sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (tm) and short cytoplasmic domain, (semaphorin) 5a, PLXNB1  -  plexin b1, DPP4  -  dipeptidyl-peptidase 4, NRP2  -  neuropilin 2, MEF2C  -  myocyte enhancer factor 2c, SASH1  -  sam and sh3 domain containing 1, ADA  -  adenosine deaminase, PLCB1  -  phospholipase c, beta 1 (phosphoinositide-specific), PTGS2  -  prostaglandin-endoperoxide synthase 2 (prostaglandin g/h synthase and cyclooxygenase), DPYSL3  -  dihydropyrimidinase-like 3, ITGB3  -  integrin, beta 3 (platelet glycoprotein iiia, antigen cd61), PREX1  -  phosphatidylinositol-3,4,5-trisphosphate-dependent rac exchange factor 1, MET  -  met proto-oncogene, DOCK1  -  dedicator of cytokinesis 1, ADORA3  -  adenosine a3 receptor, CX3CR1  -  chemokine (c-x3-c motif) receptor 1, THBS1  -  thrombospondin 1, ANXA1  -  annexin a1, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, PRKCA  -  protein kinase c, alpha, FOXP1  -  forkhead box p1, PTPRC  -  protein tyrosine phosphatase, receptor type, c, BBS4  -  bardet-biedl syndrome 4, LAMB1  -  laminin, beta 1]
GO:0050793	regulation of developmental process	4.84E-5	2.91E-2	1.47	714	176	177	64	[LILRB2  -  leukocyte immunoglobulin-like receptor, subfamily b (with tm and itim domains), member 2, CASZ1  -  castor zinc finger 1, HLA-G  -  major histocompatibility complex, class i, g, ADRB2  -  adrenoceptor beta 2, surface, SYT17  -  synaptotagmin xvii, EPPK1  -  epiplakin 1, HLA-DRB1  -  major histocompatibility complex, class ii, dr beta 1, PLXNB1  -  plexin b1, PBX1  -  pre-b-cell leukemia homeobox 1, SHANK3  -  sh3 and multiple ankyrin repeat domains 3, SHANK2  -  sh3 and multiple ankyrin repeat domains 2, PLCB1  -  phospholipase c, beta 1 (phosphoinositide-specific), BCL11A  -  b-cell cll/lymphoma 11a (zinc finger protein), NLGN1  -  neuroligin 1, DPYSL3  -  dihydropyrimidinase-like 3, TANC2  -  tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 2, DPYSL2  -  dihydropyrimidinase-like 2, OXTR  -  oxytocin receptor, CTNNB1  -  catenin (cadherin-associated protein), beta 1, 88kda, VDR  -  vitamin d (1,25- dihydroxyvitamin d3) receptor, PREX1  -  phosphatidylinositol-3,4,5-trisphosphate-dependent rac exchange factor 1, DIXDC1  -  dix domain containing 1, HLA-B  -  major histocompatibility complex, class i, b, PRICKLE2  -  prickle homolog 2 (drosophila), AR  -  androgen receptor, CUX1  -  cut-like homeobox 1, KIF13B  -  kinesin family member 13b, MSR1  -  macrophage scavenger receptor 1, SDC2  -  syndecan 2, CX3CR1  -  chemokine (c-x3-c motif) receptor 1, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, NUAK1  -  nuak family, snf1-like kinase, 1, DISC1  -  disrupted in schizophrenia 1, GPC6  -  glypican 6, MYH10  -  myosin, heavy chain 10, non-muscle, GPX1  -  glutathione peroxidase 1, NFIB  -  nuclear factor i/b, SEMA5A  -  sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (tm) and short cytoplasmic domain, (semaphorin) 5a, KANK1  -  kn motif and ankyrin repeat domains 1, PRICKLE1  -  prickle homolog 1 (drosophila), SNAP25  -  synaptosomal-associated protein, 25kda, MEF2C  -  myocyte enhancer factor 2c, NR2F1  -  nuclear receptor subfamily 2, group f, member 1, SASH1  -  sam and sh3 domain containing 1, ADA  -  adenosine deaminase, PTGS2  -  prostaglandin-endoperoxide synthase 2 (prostaglandin g/h synthase and cyclooxygenase), GPC4  -  glypican 4, ITGB3  -  integrin, beta 3 (platelet glycoprotein iiia, antigen cd61), CYFIP1  -  cytoplasmic fmr1 interacting protein 1, PTK7  -  protein tyrosine kinase 7, ST7  -  suppression of tumorigenicity 7, TRIO  -  trio rho guanine nucleotide exchange factor, EPHB2  -  eph receptor b2, DOCK1  -  dedicator of cytokinesis 1, PRKCB  -  protein kinase c, beta, THBS1  -  thrombospondin 1, ANXA1  -  annexin a1, TCF4  -  transcription factor 4, PRKCA  -  protein kinase c, alpha, NEGR1  -  neuronal growth regulator 1, FOXP1  -  forkhead box p1, HECW2  -  hect, c2 and ww domain containing e3 ubiquitin protein ligase 2, PTPRC  -  protein tyrosine phosphatase, receptor type, c, NRCAM  -  neuronal cell adhesion molecule]
GO:0051239	regulation of multicellular organismal process	5.8E-5	3.19E-2	1.39	714	224	177	77	[LILRB2  -  leukocyte immunoglobulin-like receptor, subfamily b (with tm and itim domains), member 2, CASZ1  -  castor zinc finger 1, HLA-G  -  major histocompatibility complex, class i, g, DOCK4  -  dedicator of cytokinesis 4, ADRB2  -  adrenoceptor beta 2, surface, EPPK1  -  epiplakin 1, SYT17  -  synaptotagmin xvii, HLA-DRB1  -  major histocompatibility complex, class ii, dr beta 1, PLXNB1  -  plexin b1, NRP2  -  neuropilin 2, PBX1  -  pre-b-cell leukemia homeobox 1, SHANK3  -  sh3 and multiple ankyrin repeat domains 3, NPAS2  -  neuronal pas domain protein 2, SHANK2  -  sh3 and multiple ankyrin repeat domains 2, PLCB1  -  phospholipase c, beta 1 (phosphoinositide-specific), BCL11A  -  b-cell cll/lymphoma 11a (zinc finger protein), NLGN1  -  neuroligin 1, DPYSL3  -  dihydropyrimidinase-like 3, DPYSL2  -  dihydropyrimidinase-like 2, TANC2  -  tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 2, KCNMA1  -  potassium large conductance calcium-activated channel, subfamily m, alpha member 1, OXTR  -  oxytocin receptor, CTNNB1  -  catenin (cadherin-associated protein), beta 1, 88kda, VDR  -  vitamin d (1,25- dihydroxyvitamin d3) receptor, HLA-A  -  major histocompatibility complex, class i, a, PREX1  -  phosphatidylinositol-3,4,5-trisphosphate-dependent rac exchange factor 1, DIXDC1  -  dix domain containing 1, SLC1A1  -  solute carrier family 1 (neuronal/epithelial high affinity glutamate transporter, system xag), member 1, HLA-B  -  major histocompatibility complex, class i, b, PRICKLE2  -  prickle homolog 2 (drosophila), AR  -  androgen receptor, CUX1  -  cut-like homeobox 1, KIF13B  -  kinesin family member 13b, PLAUR  -  plasminogen activator, urokinase receptor, SLC7A5  -  solute carrier family 7 (amino acid transporter light chain, l system), member 5, SDC2  -  syndecan 2, CX3CR1  -  chemokine (c-x3-c motif) receptor 1, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, DISC1  -  disrupted in schizophrenia 1, CADM1  -  cell adhesion molecule 1, TSHZ3  -  teashirt zinc finger homeobox 3, IL1R2  -  interleukin 1 receptor, type ii, GPC6  -  glypican 6, GPX1  -  glutathione peroxidase 1, NFIB  -  nuclear factor i/b, SEMA5A  -  sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (tm) and short cytoplasmic domain, (semaphorin) 5a, KANK1  -  kn motif and ankyrin repeat domains 1, SNAP25  -  synaptosomal-associated protein, 25kda, PRICKLE1  -  prickle homolog 1 (drosophila), NR4A2  -  nuclear receptor subfamily 4, group a, member 2, MEF2C  -  myocyte enhancer factor 2c, NR2F1  -  nuclear receptor subfamily 2, group f, member 1, SASH1  -  sam and sh3 domain containing 1, ADA  -  adenosine deaminase, PTGS2  -  prostaglandin-endoperoxide synthase 2 (prostaglandin g/h synthase and cyclooxygenase), GPC4  -  glypican 4, ITGB3  -  integrin, beta 3 (platelet glycoprotein iiia, antigen cd61), ITPR1  -  inositol 1,4,5-trisphosphate receptor, type 1, PTK7  -  protein tyrosine kinase 7, RNF135  -  ring finger protein 135, CYFIP1  -  cytoplasmic fmr1 interacting protein 1, EPHB2  -  eph receptor b2, MET  -  met proto-oncogene, DOCK1  -  dedicator of cytokinesis 1, VSIG4  -  v-set and immunoglobulin domain containing 4, ADORA3  -  adenosine a3 receptor, THBS1  -  thrombospondin 1, PRKCB  -  protein kinase c, beta, TCF4  -  transcription factor 4, ANXA1  -  annexin a1, FOXP1  -  forkhead box p1, HECW2  -  hect, c2 and ww domain containing e3 ubiquitin protein ligase 2, PRKCA  -  protein kinase c, alpha, NEGR1  -  neuronal growth regulator 1, PTPRC  -  protein tyrosine phosphatase, receptor type, c, ANK2  -  ankyrin 2, neuronal, NRCAM  -  neuronal cell adhesion molecule]
GO:0045597	positive regulation of cell differentiation	6.51E-5	3.31E-2	1.80	714	74	177	33	[LILRB2  -  leukocyte immunoglobulin-like receptor, subfamily b (with tm and itim domains), member 2, HLA-G  -  major histocompatibility complex, class i, g, SYT17  -  synaptotagmin xvii, HLA-DRB1  -  major histocompatibility complex, class ii, dr beta 1, PLXNB1  -  plexin b1, SEMA5A  -  sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (tm) and short cytoplasmic domain, (semaphorin) 5a, SHANK3  -  sh3 and multiple ankyrin repeat domains 3, MEF2C  -  myocyte enhancer factor 2c, SHANK2  -  sh3 and multiple ankyrin repeat domains 2, ADA  -  adenosine deaminase, PLCB1  -  phospholipase c, beta 1 (phosphoinositide-specific), PTGS2  -  prostaglandin-endoperoxide synthase 2 (prostaglandin g/h synthase and cyclooxygenase), DPYSL3  -  dihydropyrimidinase-like 3, NLGN1  -  neuroligin 1, CTNNB1  -  catenin (cadherin-associated protein), beta 1, 88kda, CYFIP1  -  cytoplasmic fmr1 interacting protein 1, PTK7  -  protein tyrosine kinase 7, VDR  -  vitamin d (1,25- dihydroxyvitamin d3) receptor, PREX1  -  phosphatidylinositol-3,4,5-trisphosphate-dependent rac exchange factor 1, AR  -  androgen receptor, EPHB2  -  eph receptor b2, CUX1  -  cut-like homeobox 1, DOCK1  -  dedicator of cytokinesis 1, MSR1  -  macrophage scavenger receptor 1, CX3CR1  -  chemokine (c-x3-c motif) receptor 1, ANXA1  -  annexin a1, TCF4  -  transcription factor 4, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, PRKCA  -  protein kinase c, alpha, NEGR1  -  neuronal growth regulator 1, DISC1  -  disrupted in schizophrenia 1, PTPRC  -  protein tyrosine phosphatase, receptor type, c, NRCAM  -  neuronal cell adhesion molecule]
GO:1901565	organonitrogen compound catabolic process	6.88E-5	3.25E-2	2.25	714	34	177	19	[TBL1X  -  transducin (beta)-like 1x-linked, GPC6  -  glypican 6, AMT  -  aminomethyltransferase, TET2  -  tet methylcytosine dioxygenase 2, GPX1  -  glutathione peroxidase 1, ABAT  -  4-aminobutyrate aminotransferase, EXT1  -  exostosin glycosyltransferase 1, CLN8  -  ceroid-lipofuscinosis, neuronal 8 (epilepsy, progressive with mental retardation), TDO2  -  tryptophan 2,3-dioxygenase, UBE2H  -  ubiquitin-conjugating enzyme e2h, GDA  -  guanine deaminase, SDC2  -  syndecan 2, ADA  -  adenosine deaminase, HECW2  -  hect, c2 and ww domain containing e3 ubiquitin protein ligase 2, MAOB  -  monoamine oxidase b, GPC4  -  glypican 4, MAOA  -  monoamine oxidase a, DPYD  -  dihydropyrimidine dehydrogenase, CTNNB1  -  catenin (cadherin-associated protein), beta 1, 88kda]
GO:0010594	regulation of endothelial cell migration	8.81E-5	3.88E-2	2.96	714	15	177	11	[SEMA5A  -  sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (tm) and short cytoplasmic domain, (semaphorin) 5a, NRP2  -  neuropilin 2, MEF2C  -  myocyte enhancer factor 2c, SASH1  -  sam and sh3 domain containing 1, THBS1  -  thrombospondin 1, ANXA1  -  annexin a1, FOXP1  -  forkhead box p1, PRKCA  -  protein kinase c, alpha, PTGS2  -  prostaglandin-endoperoxide synthase 2 (prostaglandin g/h synthase and cyclooxygenase), MET  -  met proto-oncogene, ITGB3  -  integrin, beta 3 (platelet glycoprotein iiia, antigen cd61)]
GO:0010634	positive regulation of epithelial cell migration	8.81E-5	3.64E-2	2.96	714	15	177	11	[SEMA5A  -  sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (tm) and short cytoplasmic domain, (semaphorin) 5a, NRP2  -  neuropilin 2, THBS1  -  thrombospondin 1, SASH1  -  sam and sh3 domain containing 1, ANXA1  -  annexin a1, PRKCA  -  protein kinase c, alpha, PTGS2  -  prostaglandin-endoperoxide synthase 2 (prostaglandin g/h synthase and cyclooxygenase), FOXP1  -  forkhead box p1, MET  -  met proto-oncogene, ITGB3  -  integrin, beta 3 (platelet glycoprotein iiia, antigen cd61), DOCK1  -  dedicator of cytokinesis 1]
GO:0030334	regulation of cell migration	9.06E-5	3.52E-2	1.94	714	54	177	26	[DOCK4  -  dedicator of cytokinesis 4, EPPK1  -  epiplakin 1, SEMA5A  -  sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (tm) and short cytoplasmic domain, (semaphorin) 5a, KANK1  -  kn motif and ankyrin repeat domains 1, DPP4  -  dipeptidyl-peptidase 4, PLXNB1  -  plexin b1, NRP2  -  neuropilin 2, MEF2C  -  myocyte enhancer factor 2c, SASH1  -  sam and sh3 domain containing 1, ADA  -  adenosine deaminase, PLCB1  -  phospholipase c, beta 1 (phosphoinositide-specific), PTGS2  -  prostaglandin-endoperoxide synthase 2 (prostaglandin g/h synthase and cyclooxygenase), DPYSL3  -  dihydropyrimidinase-like 3, ITGB3  -  integrin, beta 3 (platelet glycoprotein iiia, antigen cd61), PREX1  -  phosphatidylinositol-3,4,5-trisphosphate-dependent rac exchange factor 1, MET  -  met proto-oncogene, DOCK1  -  dedicator of cytokinesis 1, ADORA3  -  adenosine a3 receptor, CX3CR1  -  chemokine (c-x3-c motif) receptor 1, THBS1  -  thrombospondin 1, ANXA1  -  annexin a1, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, FOXP1  -  forkhead box p1, PRKCA  -  protein kinase c, alpha, PTPRC  -  protein tyrosine phosphatase, receptor type, c, LAMB1  -  laminin, beta 1]
GO:2000026	regulation of multicellular organismal development	9.69E-5	3.56E-2	1.50	714	151	177	56	[LILRB2  -  leukocyte immunoglobulin-like receptor, subfamily b (with tm and itim domains), member 2, CASZ1  -  castor zinc finger 1, HLA-G  -  major histocompatibility complex, class i, g, ADRB2  -  adrenoceptor beta 2, surface, SYT17  -  synaptotagmin xvii, HLA-DRB1  -  major histocompatibility complex, class ii, dr beta 1, PLXNB1  -  plexin b1, PBX1  -  pre-b-cell leukemia homeobox 1, SHANK3  -  sh3 and multiple ankyrin repeat domains 3, SHANK2  -  sh3 and multiple ankyrin repeat domains 2, PLCB1  -  phospholipase c, beta 1 (phosphoinositide-specific), BCL11A  -  b-cell cll/lymphoma 11a (zinc finger protein), DPYSL3  -  dihydropyrimidinase-like 3, NLGN1  -  neuroligin 1, DPYSL2  -  dihydropyrimidinase-like 2, TANC2  -  tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 2, OXTR  -  oxytocin receptor, CTNNB1  -  catenin (cadherin-associated protein), beta 1, 88kda, VDR  -  vitamin d (1,25- dihydroxyvitamin d3) receptor, PREX1  -  phosphatidylinositol-3,4,5-trisphosphate-dependent rac exchange factor 1, HLA-B  -  major histocompatibility complex, class i, b, DIXDC1  -  dix domain containing 1, PRICKLE2  -  prickle homolog 2 (drosophila), AR  -  androgen receptor, CUX1  -  cut-like homeobox 1, KIF13B  -  kinesin family member 13b, SDC2  -  syndecan 2, CX3CR1  -  chemokine (c-x3-c motif) receptor 1, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, DISC1  -  disrupted in schizophrenia 1, GPC6  -  glypican 6, GPX1  -  glutathione peroxidase 1, NFIB  -  nuclear factor i/b, KANK1  -  kn motif and ankyrin repeat domains 1, SEMA5A  -  sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (tm) and short cytoplasmic domain, (semaphorin) 5a, SNAP25  -  synaptosomal-associated protein, 25kda, PRICKLE1  -  prickle homolog 1 (drosophila), MEF2C  -  myocyte enhancer factor 2c, SASH1  -  sam and sh3 domain containing 1, NR2F1  -  nuclear receptor subfamily 2, group f, member 1, ADA  -  adenosine deaminase, PTGS2  -  prostaglandin-endoperoxide synthase 2 (prostaglandin g/h synthase and cyclooxygenase), GPC4  -  glypican 4, PTK7  -  protein tyrosine kinase 7, CYFIP1  -  cytoplasmic fmr1 interacting protein 1, EPHB2  -  eph receptor b2, THBS1  -  thrombospondin 1, PRKCB  -  protein kinase c, beta, ANXA1  -  annexin a1, TCF4  -  transcription factor 4, NEGR1  -  neuronal growth regulator 1, PRKCA  -  protein kinase c, alpha, FOXP1  -  forkhead box p1, HECW2  -  hect, c2 and ww domain containing e3 ubiquitin protein ligase 2, PTPRC  -  protein tyrosine phosphatase, receptor type, c, NRCAM  -  neuronal cell adhesion molecule]
GO:0001817	regulation of cytokine production	1.18E-4	4.09E-2	2.19	714	35	177	19	[CADM1  -  cell adhesion molecule 1, HLA-A  -  major histocompatibility complex, class i, a, LILRB2  -  leukocyte immunoglobulin-like receptor, subfamily b (with tm and itim domains), member 2, HLA-B  -  major histocompatibility complex, class i, b, HLA-G  -  major histocompatibility complex, class i, g, IL1R2  -  interleukin 1 receptor, type ii, HLA-DRB1  -  major histocompatibility complex, class ii, dr beta 1, VSIG4  -  v-set and immunoglobulin domain containing 4, SLC7A5  -  solute carrier family 7 (amino acid transporter light chain, l system), member 5, CX3CR1  -  chemokine (c-x3-c motif) receptor 1, THBS1  -  thrombospondin 1, ANXA1  -  annexin a1, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, FOXP1  -  forkhead box p1, PLCB1  -  phospholipase c, beta 1 (phosphoinositide-specific), PTGS2  -  prostaglandin-endoperoxide synthase 2 (prostaglandin g/h synthase and cyclooxygenase), PTPRC  -  protein tyrosine phosphatase, receptor type, c, CTNNB1  -  catenin (cadherin-associated protein), beta 1, 88kda, RNF135  -  ring finger protein 135]
GO:0030335	positive regulation of cell migration	1.37E-4	4.52E-2	2.29	714	30	177	17	[PREX1  -  phosphatidylinositol-3,4,5-trisphosphate-dependent rac exchange factor 1, DOCK4  -  dedicator of cytokinesis 4, MET  -  met proto-oncogene, DOCK1  -  dedicator of cytokinesis 1, SEMA5A  -  sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (tm) and short cytoplasmic domain, (semaphorin) 5a, NRP2  -  neuropilin 2, SASH1  -  sam and sh3 domain containing 1, THBS1  -  thrombospondin 1, CX3CR1  -  chemokine (c-x3-c motif) receptor 1, ANXA1  -  annexin a1, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, PRKCA  -  protein kinase c, alpha, FOXP1  -  forkhead box p1, PTGS2  -  prostaglandin-endoperoxide synthase 2 (prostaglandin g/h synthase and cyclooxygenase), PTPRC  -  protein tyrosine phosphatase, receptor type, c, ITGB3  -  integrin, beta 3 (platelet glycoprotein iiia, antigen cd61), LAMB1  -  laminin, beta 1]
GO:2000147	positive regulation of cell motility	1.37E-4	4.31E-2	2.29	714	30	177	17	[PREX1  -  phosphatidylinositol-3,4,5-trisphosphate-dependent rac exchange factor 1, DOCK4  -  dedicator of cytokinesis 4, MET  -  met proto-oncogene, DOCK1  -  dedicator of cytokinesis 1, SEMA5A  -  sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (tm) and short cytoplasmic domain, (semaphorin) 5a, NRP2  -  neuropilin 2, SASH1  -  sam and sh3 domain containing 1, THBS1  -  thrombospondin 1, CX3CR1  -  chemokine (c-x3-c motif) receptor 1, ANXA1  -  annexin a1, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, FOXP1  -  forkhead box p1, PRKCA  -  protein kinase c, alpha, PTGS2  -  prostaglandin-endoperoxide synthase 2 (prostaglandin g/h synthase and cyclooxygenase), PTPRC  -  protein tyrosine phosphatase, receptor type, c, ITGB3  -  integrin, beta 3 (platelet glycoprotein iiia, antigen cd61), LAMB1  -  laminin, beta 1]
GO:0040017	positive regulation of locomotion	2.37E-4	7.13E-2	2.21	714	31	177	17	[PREX1  -  phosphatidylinositol-3,4,5-trisphosphate-dependent rac exchange factor 1, DOCK4  -  dedicator of cytokinesis 4, MET  -  met proto-oncogene, DOCK1  -  dedicator of cytokinesis 1, SEMA5A  -  sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (tm) and short cytoplasmic domain, (semaphorin) 5a, NRP2  -  neuropilin 2, SASH1  -  sam and sh3 domain containing 1, CX3CR1  -  chemokine (c-x3-c motif) receptor 1, THBS1  -  thrombospondin 1, ANXA1  -  annexin a1, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, PRKCA  -  protein kinase c, alpha, FOXP1  -  forkhead box p1, PTGS2  -  prostaglandin-endoperoxide synthase 2 (prostaglandin g/h synthase and cyclooxygenase), PTPRC  -  protein tyrosine phosphatase, receptor type, c, ITGB3  -  integrin, beta 3 (platelet glycoprotein iiia, antigen cd61), LAMB1  -  laminin, beta 1]
GO:0051272	positive regulation of cellular component movement	2.37E-4	6.82E-2	2.21	714	31	177	17	[PREX1  -  phosphatidylinositol-3,4,5-trisphosphate-dependent rac exchange factor 1, DOCK4  -  dedicator of cytokinesis 4, MET  -  met proto-oncogene, DOCK1  -  dedicator of cytokinesis 1, SEMA5A  -  sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (tm) and short cytoplasmic domain, (semaphorin) 5a, NRP2  -  neuropilin 2, SASH1  -  sam and sh3 domain containing 1, THBS1  -  thrombospondin 1, CX3CR1  -  chemokine (c-x3-c motif) receptor 1, ANXA1  -  annexin a1, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, PRKCA  -  protein kinase c, alpha, FOXP1  -  forkhead box p1, PTGS2  -  prostaglandin-endoperoxide synthase 2 (prostaglandin g/h synthase and cyclooxygenase), PTPRC  -  protein tyrosine phosphatase, receptor type, c, ITGB3  -  integrin, beta 3 (platelet glycoprotein iiia, antigen cd61), LAMB1  -  laminin, beta 1]
GO:0030155	regulation of cell adhesion	2.56E-4	7.05E-2	1.97	714	45	177	22	[HLA-A  -  major histocompatibility complex, class i, a, LILRB2  -  leukocyte immunoglobulin-like receptor, subfamily b (with tm and itim domains), member 2, PREX1  -  phosphatidylinositol-3,4,5-trisphosphate-dependent rac exchange factor 1, HLA-G  -  major histocompatibility complex, class i, g, DOCK1  -  dedicator of cytokinesis 1, HLA-DRB1  -  major histocompatibility complex, class ii, dr beta 1, SEMA5A  -  sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (tm) and short cytoplasmic domain, (semaphorin) 5a, KANK1  -  kn motif and ankyrin repeat domains 1, DPP4  -  dipeptidyl-peptidase 4, PLXNB1  -  plexin b1, VSIG4  -  v-set and immunoglobulin domain containing 4, PLAUR  -  plasminogen activator, urokinase receptor, THBS1  -  thrombospondin 1, ANXA1  -  annexin a1, CASK  -  calcium/calmodulin-dependent serine protein kinase (maguk family), ADA  -  adenosine deaminase, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, PRKCA  -  protein kinase c, alpha, NUAK1  -  nuak family, snf1-like kinase, 1, DISC1  -  disrupted in schizophrenia 1, PTPRC  -  protein tyrosine phosphatase, receptor type, c, ANK3  -  ankyrin 3, node of ranvier (ankyrin g)]
GO:0010632	regulation of epithelial cell migration	2.73E-4	7.21E-2	2.50	714	21	177	13	[MET  -  met proto-oncogene, DOCK1  -  dedicator of cytokinesis 1, EPPK1  -  epiplakin 1, SEMA5A  -  sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (tm) and short cytoplasmic domain, (semaphorin) 5a, NRP2  -  neuropilin 2, MEF2C  -  myocyte enhancer factor 2c, THBS1  -  thrombospondin 1, SASH1  -  sam and sh3 domain containing 1, ANXA1  -  annexin a1, FOXP1  -  forkhead box p1, PRKCA  -  protein kinase c, alpha, PTGS2  -  prostaglandin-endoperoxide synthase 2 (prostaglandin g/h synthase and cyclooxygenase), ITGB3  -  integrin, beta 3 (platelet glycoprotein iiia, antigen cd61)]
GO:0048584	positive regulation of response to stimulus	2.76E-4	7.02E-2	1.51	714	128	177	48	[CADM1  -  cell adhesion molecule 1, HLA-G  -  major histocompatibility complex, class i, g, NEO1  -  neogenin 1, GPX1  -  glutathione peroxidase 1, ADRB2  -  adrenoceptor beta 2, surface, HLA-DRB1  -  major histocompatibility complex, class ii, dr beta 1, KANK1  -  kn motif and ankyrin repeat domains 1, SEMA5A  -  sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (tm) and short cytoplasmic domain, (semaphorin) 5a, PLXNB1  -  plexin b1, SHANK3  -  sh3 and multiple ankyrin repeat domains 3, MEF2C  -  myocyte enhancer factor 2c, SASH1  -  sam and sh3 domain containing 1, ADA  -  adenosine deaminase, SHANK2  -  sh3 and multiple ankyrin repeat domains 2, NPAS2  -  neuronal pas domain protein 2, PLCB1  -  phospholipase c, beta 1 (phosphoinositide-specific), PTGS2  -  prostaglandin-endoperoxide synthase 2 (prostaglandin g/h synthase and cyclooxygenase), MAOA  -  monoamine oxidase a, NLGN1  -  neuroligin 1, ITGB3  -  integrin, beta 3 (platelet glycoprotein iiia, antigen cd61), CYFIP1  -  cytoplasmic fmr1 interacting protein 1, RNF135  -  ring finger protein 135, PTK7  -  protein tyrosine kinase 7, HLA-A  -  major histocompatibility complex, class i, a, STXBP1  -  syntaxin binding protein 1, HLA-B  -  major histocompatibility complex, class i, b, DIXDC1  -  dix domain containing 1, NR3C2  -  nuclear receptor subfamily 3, group c, member 2, AR  -  androgen receptor, TBL1X  -  transducin (beta)-like 1x-linked, EPHB2  -  eph receptor b2, MET  -  met proto-oncogene, DOCK1  -  dedicator of cytokinesis 1, TCF7L2  -  transcription factor 7-like 2 (t-cell specific, hmg-box), VSIG4  -  v-set and immunoglobulin domain containing 4, PLAUR  -  plasminogen activator, urokinase receptor, SLC7A5  -  solute carrier family 7 (amino acid transporter light chain, l system), member 5, AUTS2  -  autism susceptibility candidate 2, PRKCB  -  protein kinase c, beta, THBS1  -  thrombospondin 1, CX3CR1  -  chemokine (c-x3-c motif) receptor 1, ANXA1  -  annexin a1, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, FOXP1  -  forkhead box p1, PRKCA  -  protein kinase c, alpha, DISC1  -  disrupted in schizophrenia 1, WWOX  -  ww domain containing oxidoreductase, PTPRC  -  protein tyrosine phosphatase, receptor type, c]
GO:0051270	regulation of cellular component movement	2.79E-4	6.82E-2	1.79	714	63	177	28	[DOCK4  -  dedicator of cytokinesis 4, EPPK1  -  epiplakin 1, KANK1  -  kn motif and ankyrin repeat domains 1, SEMA5A  -  sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (tm) and short cytoplasmic domain, (semaphorin) 5a, DPP4  -  dipeptidyl-peptidase 4, PLXNB1  -  plexin b1, NRP2  -  neuropilin 2, MEF2C  -  myocyte enhancer factor 2c, SASH1  -  sam and sh3 domain containing 1, ADA  -  adenosine deaminase, PLCB1  -  phospholipase c, beta 1 (phosphoinositide-specific), PTGS2  -  prostaglandin-endoperoxide synthase 2 (prostaglandin g/h synthase and cyclooxygenase), DPYSL3  -  dihydropyrimidinase-like 3, ITGB3  -  integrin, beta 3 (platelet glycoprotein iiia, antigen cd61), PREX1  -  phosphatidylinositol-3,4,5-trisphosphate-dependent rac exchange factor 1, MET  -  met proto-oncogene, DOCK1  -  dedicator of cytokinesis 1, ADORA3  -  adenosine a3 receptor, CX3CR1  -  chemokine (c-x3-c motif) receptor 1, THBS1  -  thrombospondin 1, ANXA1  -  annexin a1, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, FOXP1  -  forkhead box p1, PRKCA  -  protein kinase c, alpha, PTPRC  -  protein tyrosine phosphatase, receptor type, c, ANK2  -  ankyrin 2, neuronal, BBS4  -  bardet-biedl syndrome 4, LAMB1  -  laminin, beta 1]
GO:0001818	negative regulation of cytokine production	3.53E-4	8.32E-2	3.23	714	10	177	8	[HLA-DRB1  -  major histocompatibility complex, class ii, dr beta 1, VSIG4  -  v-set and immunoglobulin domain containing 4, THBS1  -  thrombospondin 1, CX3CR1  -  chemokine (c-x3-c motif) receptor 1, ANXA1  -  annexin a1, IL1R2  -  interleukin 1 receptor, type ii, PTPRC  -  protein tyrosine phosphatase, receptor type, c, RNF135  -  ring finger protein 135]
GO:0050777	negative regulation of immune response	3.53E-4	8.03E-2	3.23	714	10	177	8	[HLA-DRB1  -  major histocompatibility complex, class ii, dr beta 1, HLA-A  -  major histocompatibility complex, class i, a, VSIG4  -  v-set and immunoglobulin domain containing 4, HLA-B  -  major histocompatibility complex, class i, b, HLA-G  -  major histocompatibility complex, class i, g, ANXA1  -  annexin a1, PTPRC  -  protein tyrosine phosphatase, receptor type, c, GPX1  -  glutathione peroxidase 1]
GO:0002822	regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains	3.53E-4	7.76E-2	3.23	714	10	177	8	[HLA-A  -  major histocompatibility complex, class i, a, HLA-DRB1  -  major histocompatibility complex, class ii, dr beta 1, HLA-B  -  major histocompatibility complex, class i, b, MEF2C  -  myocyte enhancer factor 2c, HLA-G  -  major histocompatibility complex, class i, g, ADA  -  adenosine deaminase, ANXA1  -  annexin a1, PTPRC  -  protein tyrosine phosphatase, receptor type, c]
GO:0002819	regulation of adaptive immune response	3.53E-4	7.51E-2	3.23	714	10	177	8	[HLA-DRB1  -  major histocompatibility complex, class ii, dr beta 1, HLA-A  -  major histocompatibility complex, class i, a, HLA-B  -  major histocompatibility complex, class i, b, MEF2C  -  myocyte enhancer factor 2c, HLA-G  -  major histocompatibility complex, class i, g, ANXA1  -  annexin a1, ADA  -  adenosine deaminase, PTPRC  -  protein tyrosine phosphatase, receptor type, c]
GO:0040012	regulation of locomotion	3.96E-4	8.19E-2	1.79	714	61	177	27	[DOCK4  -  dedicator of cytokinesis 4, EPPK1  -  epiplakin 1, KANK1  -  kn motif and ankyrin repeat domains 1, SEMA5A  -  sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (tm) and short cytoplasmic domain, (semaphorin) 5a, DPP4  -  dipeptidyl-peptidase 4, PLXNB1  -  plexin b1, NRP2  -  neuropilin 2, MEF2C  -  myocyte enhancer factor 2c, SASH1  -  sam and sh3 domain containing 1, ADA  -  adenosine deaminase, PLCB1  -  phospholipase c, beta 1 (phosphoinositide-specific), PTGS2  -  prostaglandin-endoperoxide synthase 2 (prostaglandin g/h synthase and cyclooxygenase), DPYSL3  -  dihydropyrimidinase-like 3, ITGB3  -  integrin, beta 3 (platelet glycoprotein iiia, antigen cd61), PREX1  -  phosphatidylinositol-3,4,5-trisphosphate-dependent rac exchange factor 1, MET  -  met proto-oncogene, DOCK1  -  dedicator of cytokinesis 1, ADORA3  -  adenosine a3 receptor, CX3CR1  -  chemokine (c-x3-c motif) receptor 1, THBS1  -  thrombospondin 1, ANXA1  -  annexin a1, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, FOXP1  -  forkhead box p1, PRKCA  -  protein kinase c, alpha, PTPRC  -  protein tyrosine phosphatase, receptor type, c, BBS4  -  bardet-biedl syndrome 4, LAMB1  -  laminin, beta 1]
GO:0045765	regulation of angiogenesis	4.91E-4	9.83E-2	2.61	714	17	177	11	[SEMA5A  -  sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (tm) and short cytoplasmic domain, (semaphorin) 5a, HLA-G  -  major histocompatibility complex, class i, g, CX3CR1  -  chemokine (c-x3-c motif) receptor 1, THBS1  -  thrombospondin 1, PRKCB  -  protein kinase c, beta, SASH1  -  sam and sh3 domain containing 1, ANXA1  -  annexin a1, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, PTGS2  -  prostaglandin-endoperoxide synthase 2 (prostaglandin g/h synthase and cyclooxygenase), PRKCA  -  protein kinase c, alpha, CTNNB1  -  catenin (cadherin-associated protein), beta 1, 88kda]
GO:1901342	regulation of vasculature development	4.91E-4	9.55E-2	2.61	714	17	177	11	[SEMA5A  -  sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (tm) and short cytoplasmic domain, (semaphorin) 5a, HLA-G  -  major histocompatibility complex, class i, g, CX3CR1  -  chemokine (c-x3-c motif) receptor 1, THBS1  -  thrombospondin 1, PRKCB  -  protein kinase c, beta, SASH1  -  sam and sh3 domain containing 1, ANXA1  -  annexin a1, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, PRKCA  -  protein kinase c, alpha, PTGS2  -  prostaglandin-endoperoxide synthase 2 (prostaglandin g/h synthase and cyclooxygenase), CTNNB1  -  catenin (cadherin-associated protein), beta 1, 88kda]
GO:0045664	regulation of neuron differentiation	5.15E-4	9.72E-2	1.72	714	68	177	29	[CASZ1  -  castor zinc finger 1, SYT17  -  synaptotagmin xvii, PLXNB1  -  plexin b1, KANK1  -  kn motif and ankyrin repeat domains 1, SEMA5A  -  sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (tm) and short cytoplasmic domain, (semaphorin) 5a, PBX1  -  pre-b-cell leukemia homeobox 1, SNAP25  -  synaptosomal-associated protein, 25kda, SHANK3  -  sh3 and multiple ankyrin repeat domains 3, MEF2C  -  myocyte enhancer factor 2c, NR2F1  -  nuclear receptor subfamily 2, group f, member 1, SHANK2  -  sh3 and multiple ankyrin repeat domains 2, BCL11A  -  b-cell cll/lymphoma 11a (zinc finger protein), NLGN1  -  neuroligin 1, DPYSL3  -  dihydropyrimidinase-like 3, TANC2  -  tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 2, DPYSL2  -  dihydropyrimidinase-like 2, PTK7  -  protein tyrosine kinase 7, CYFIP1  -  cytoplasmic fmr1 interacting protein 1, PREX1  -  phosphatidylinositol-3,4,5-trisphosphate-dependent rac exchange factor 1, DIXDC1  -  dix domain containing 1, CUX1  -  cut-like homeobox 1, EPHB2  -  eph receptor b2, KIF13B  -  kinesin family member 13b, SDC2  -  syndecan 2, TCF4  -  transcription factor 4, NEGR1  -  neuronal growth regulator 1, HECW2  -  hect, c2 and ww domain containing e3 ubiquitin protein ligase 2, DISC1  -  disrupted in schizophrenia 1, NRCAM  -  neuronal cell adhesion molecule]
GO:0051094	positive regulation of developmental process	5.19E-4	9.53E-2	1.58	714	97	177	38	[LILRB2  -  leukocyte immunoglobulin-like receptor, subfamily b (with tm and itim domains), member 2, HLA-G  -  major histocompatibility complex, class i, g, ADRB2  -  adrenoceptor beta 2, surface, SYT17  -  synaptotagmin xvii, HLA-DRB1  -  major histocompatibility complex, class ii, dr beta 1, SEMA5A  -  sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (tm) and short cytoplasmic domain, (semaphorin) 5a, PLXNB1  -  plexin b1, SHANK3  -  sh3 and multiple ankyrin repeat domains 3, MEF2C  -  myocyte enhancer factor 2c, SASH1  -  sam and sh3 domain containing 1, ADA  -  adenosine deaminase, SHANK2  -  sh3 and multiple ankyrin repeat domains 2, PTGS2  -  prostaglandin-endoperoxide synthase 2 (prostaglandin g/h synthase and cyclooxygenase), PLCB1  -  phospholipase c, beta 1 (phosphoinositide-specific), NLGN1  -  neuroligin 1, DPYSL3  -  dihydropyrimidinase-like 3, OXTR  -  oxytocin receptor, CYFIP1  -  cytoplasmic fmr1 interacting protein 1, PTK7  -  protein tyrosine kinase 7, CTNNB1  -  catenin (cadherin-associated protein), beta 1, 88kda, VDR  -  vitamin d (1,25- dihydroxyvitamin d3) receptor, PREX1  -  phosphatidylinositol-3,4,5-trisphosphate-dependent rac exchange factor 1, AR  -  androgen receptor, EPHB2  -  eph receptor b2, CUX1  -  cut-like homeobox 1, DOCK1  -  dedicator of cytokinesis 1, MSR1  -  macrophage scavenger receptor 1, PRKCB  -  protein kinase c, beta, THBS1  -  thrombospondin 1, CX3CR1  -  chemokine (c-x3-c motif) receptor 1, ANXA1  -  annexin a1, TCF4  -  transcription factor 4, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, PRKCA  -  protein kinase c, alpha, NEGR1  -  neuronal growth regulator 1, DISC1  -  disrupted in schizophrenia 1, PTPRC  -  protein tyrosine phosphatase, receptor type, c, NRCAM  -  neuronal cell adhesion molecule]
GO:0006935	chemotaxis	6.45E-4	1.15E-1	2.69	714	15	177	10	[DPP4  -  dipeptidyl-peptidase 4, SEMA5A  -  sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (tm) and short cytoplasmic domain, (semaphorin) 5a, PREX1  -  phosphatidylinositol-3,4,5-trisphosphate-dependent rac exchange factor 1, NRP2  -  neuropilin 2, PLAUR  -  plasminogen activator, urokinase receptor, CX3CR1  -  chemokine (c-x3-c motif) receptor 1, ANXA1  -  annexin a1, DOCK4  -  dedicator of cytokinesis 4, MET  -  met proto-oncogene, ITGB3  -  integrin, beta 3 (platelet glycoprotein iiia, antigen cd61)]
GO:0051241	negative regulation of multicellular organismal process	6.64E-4	1.15E-1	1.68	714	72	177	30	[HLA-G  -  major histocompatibility complex, class i, g, DOCK4  -  dedicator of cytokinesis 4, IL1R2  -  interleukin 1 receptor, type ii, ADRB2  -  adrenoceptor beta 2, surface, EPPK1  -  epiplakin 1, HLA-DRB1  -  major histocompatibility complex, class ii, dr beta 1, NFIB  -  nuclear factor i/b, SEMA5A  -  sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (tm) and short cytoplasmic domain, (semaphorin) 5a, KANK1  -  kn motif and ankyrin repeat domains 1, PBX1  -  pre-b-cell leukemia homeobox 1, PRICKLE1  -  prickle homolog 1 (drosophila), MEF2C  -  myocyte enhancer factor 2c, NR2F1  -  nuclear receptor subfamily 2, group f, member 1, ADA  -  adenosine deaminase, BCL11A  -  b-cell cll/lymphoma 11a (zinc finger protein), DPYSL3  -  dihydropyrimidinase-like 3, NLGN1  -  neuroligin 1, OXTR  -  oxytocin receptor, KCNMA1  -  potassium large conductance calcium-activated channel, subfamily m, alpha member 1, CTNNB1  -  catenin (cadherin-associated protein), beta 1, 88kda, RNF135  -  ring finger protein 135, DIXDC1  -  dix domain containing 1, EPHB2  -  eph receptor b2, VSIG4  -  v-set and immunoglobulin domain containing 4, PLAUR  -  plasminogen activator, urokinase receptor, THBS1  -  thrombospondin 1, CX3CR1  -  chemokine (c-x3-c motif) receptor 1, ANXA1  -  annexin a1, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, PTPRC  -  protein tyrosine phosphatase, receptor type, c]
GO:0045785	positive regulation of cell adhesion	6.69E-4	1.13E-1	2.26	714	25	177	14	[HLA-A  -  major histocompatibility complex, class i, a, LILRB2  -  leukocyte immunoglobulin-like receptor, subfamily b (with tm and itim domains), member 2, PREX1  -  phosphatidylinositol-3,4,5-trisphosphate-dependent rac exchange factor 1, HLA-G  -  major histocompatibility complex, class i, g, DOCK1  -  dedicator of cytokinesis 1, HLA-DRB1  -  major histocompatibility complex, class ii, dr beta 1, DPP4  -  dipeptidyl-peptidase 4, PLAUR  -  plasminogen activator, urokinase receptor, ADA  -  adenosine deaminase, ANXA1  -  annexin a1, PRKCA  -  protein kinase c, alpha, DISC1  -  disrupted in schizophrenia 1, PTPRC  -  protein tyrosine phosphatase, receptor type, c, ANK3  -  ankyrin 3, node of ranvier (ankyrin g)]
GO:0006952	defense response	7.01E-4	1.16E-1	2.02	714	36	177	18	[HLA-A  -  major histocompatibility complex, class i, a, LILRB2  -  leukocyte immunoglobulin-like receptor, subfamily b (with tm and itim domains), member 2, HLA-B  -  major histocompatibility complex, class i, b, SLC1A1  -  solute carrier family 1 (neuronal/epithelial high affinity glutamate transporter, system xag), member 1, HLA-G  -  major histocompatibility complex, class i, g, EXT1  -  exostosin glycosyltransferase 1, HLA-DRB1  -  major histocompatibility complex, class ii, dr beta 1, DPP4  -  dipeptidyl-peptidase 4, ADORA3  -  adenosine a3 receptor, VSIG4  -  v-set and immunoglobulin domain containing 4, CX3CR1  -  chemokine (c-x3-c motif) receptor 1, THBS1  -  thrombospondin 1, ANXA1  -  annexin a1, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, PTGS2  -  prostaglandin-endoperoxide synthase 2 (prostaglandin g/h synthase and cyclooxygenase), PTPRC  -  protein tyrosine phosphatase, receptor type, c, SCN9A  -  sodium channel, voltage-gated, type ix, alpha subunit, RNF135  -  ring finger protein 135]
GO:0010975	regulation of neuron projection development	7.96E-4	1.28E-1	1.77	714	57	177	25	[SYT17  -  synaptotagmin xvii, PLXNB1  -  plexin b1, SEMA5A  -  sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (tm) and short cytoplasmic domain, (semaphorin) 5a, KANK1  -  kn motif and ankyrin repeat domains 1, SNAP25  -  synaptosomal-associated protein, 25kda, SHANK3  -  sh3 and multiple ankyrin repeat domains 3, MEF2C  -  myocyte enhancer factor 2c, NR2F1  -  nuclear receptor subfamily 2, group f, member 1, SHANK2  -  sh3 and multiple ankyrin repeat domains 2, BCL11A  -  b-cell cll/lymphoma 11a (zinc finger protein), DPYSL3  -  dihydropyrimidinase-like 3, NLGN1  -  neuroligin 1, TANC2  -  tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 2, DPYSL2  -  dihydropyrimidinase-like 2, CYFIP1  -  cytoplasmic fmr1 interacting protein 1, PTK7  -  protein tyrosine kinase 7, PREX1  -  phosphatidylinositol-3,4,5-trisphosphate-dependent rac exchange factor 1, CUX1  -  cut-like homeobox 1, EPHB2  -  eph receptor b2, KIF13B  -  kinesin family member 13b, SDC2  -  syndecan 2, NEGR1  -  neuronal growth regulator 1, HECW2  -  hect, c2 and ww domain containing e3 ubiquitin protein ligase 2, DISC1  -  disrupted in schizophrenia 1, NRCAM  -  neuronal cell adhesion molecule]
GO:0002699	positive regulation of immune effector process	8.26E-4	1.3E-1	2.79	714	13	177	9	[HLA-DRB1  -  major histocompatibility complex, class ii, dr beta 1, CADM1  -  cell adhesion molecule 1, HLA-A  -  major histocompatibility complex, class i, a, STXBP1  -  syntaxin binding protein 1, SLC7A5  -  solute carrier family 7 (amino acid transporter light chain, l system), member 5, HLA-B  -  major histocompatibility complex, class i, b, HLA-G  -  major histocompatibility complex, class i, g, ANXA1  -  annexin a1, PTPRC  -  protein tyrosine phosphatase, receptor type, c]
GO:0030198	extracellular matrix organization	8.26E-4	1.27E-1	2.79	714	13	177	9	[PXDN  -  peroxidasin homolog (drosophila), COL28A1  -  collagen, type xxviii, alpha 1, ST7  -  suppression of tumorigenicity 7, THBS1  -  thrombospondin 1, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, MYO1E  -  myosin ie, ITGB3  -  integrin, beta 3 (platelet glycoprotein iiia, antigen cd61), EXT1  -  exostosin glycosyltransferase 1, LAMB1  -  laminin, beta 1]
GO:0032655	regulation of interleukin-12 production	8.97E-4	1.35E-1	4.03	714	5	177	5	[HLA-B  -  major histocompatibility complex, class i, b, HLA-G  -  major histocompatibility complex, class i, g, THBS1  -  thrombospondin 1, PLCB1  -  phospholipase c, beta 1 (phosphoinositide-specific), FOXP1  -  forkhead box p1]
GO:0002683	negative regulation of immune system process	9.41E-4	1.38E-1	2.28	714	23	177	13	[HLA-A  -  major histocompatibility complex, class i, a, LILRB2  -  leukocyte immunoglobulin-like receptor, subfamily b (with tm and itim domains), member 2, HLA-B  -  major histocompatibility complex, class i, b, HLA-G  -  major histocompatibility complex, class i, g, GPX1  -  glutathione peroxidase 1, HLA-DRB1  -  major histocompatibility complex, class ii, dr beta 1, DPP4  -  dipeptidyl-peptidase 4, VSIG4  -  v-set and immunoglobulin domain containing 4, THBS1  -  thrombospondin 1, ADA  -  adenosine deaminase, ANXA1  -  annexin a1, PLCB1  -  phospholipase c, beta 1 (phosphoinositide-specific), PTPRC  -  protein tyrosine phosphatase, receptor type, c]
